Alcon Inc. (SWX:ALC)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 31.68B |
| Revenue (ttm) | 7.97B |
| Net Income (ttm) | 853.34M |
| Shares Out | 494.40M |
| EPS (ttm) | 1.72 |
| PE Ratio | 37.31 |
| Forward PE | 24.67 |
| Dividend | 0.28 (0.44%) |
| Ex-Dividend Date | May 13, 2025 |
| Volume | 1,220,218 |
| Average Volume | 1,399,655 |
| Open | 63.72 |
| Previous Close | 63.46 |
| Day's Range | 63.50 - 64.58 |
| 52-Week Range | 62.56 - 87.00 |
| Beta | 0.69 |
| RSI | 40.03 |
| Earnings Date | Aug 20, 2025 |
About Alcon
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ... [Read more]
Financial Performance
In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.
Financial numbers in USD Financial StatementsNews
Broadwood Opposes Alcon's Acquisition Proposal for STAAR Surgical (STAA)
Broadwood Opposes Alcon's Acquisition Proposal for STAAR Surgical (STAA)
STAAR Surgical's largest holder to vote against Alcon bid
Alcon to Present at 2025 Baird Global Healthcare Conference
GENEVA--(BUSINESS WIRE)--Alcon to Present at 2025 Baird Global Healthcare Conference.
Alcon to Present at 2025 Baird Global Healthcare Conference
GENEVA--(BUSINESS WIRE)--Alcon to Present at 2025 Baird Global Healthcare Conference.
Trouble Ahead for Alcon Shares
Alcon Inc. (NYSE: ALC) is showing clear signs of weakness on its weekly chart. The stock has entered Phase 8 of its 18-phase Adhishthana cycle, and a critical breakdown from its Cakra formation has t...
Trouble Ahead for Alcon Shares
Alcon Inc. is showing clear signs of weakness on its weekly chart. The stock has entered Phase 8 of its 18-phase Adhishthana cycle, and a critical breakdown from its Cakra formation has triggered what...
Alcon downgraded at J.P. Morgan on Q2 results
These Analysts Slash Their Forecasts On Alcon After Q2 Earnings
Alcon Inc (NYSE: ALC) posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact. The company reported adjusted earnings of 7...
These Analysts Slash Their Forecasts On Alcon After Q2 Earnings
Alcon Inc ALC posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact.
Alcon Inc. 2025 Q2 - Results - Earnings Call Presentation
Alcon Inc. (ALC) Q2 2025 Earnings Call Transcript
Alcon slips 9% on top-line miss, updated 2025 guidance
Alcon: More Than Meets The Eye
La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the S&P 500 futures falling around 0.1% on Wednesday. Shares of La-Z-Boy Incorporated (NYSE: LZB) fell sharply in pre-market trading as the c...
La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the S&P 500 futures falling around 0.1% on Wednesday.
Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit
The company said it expects a $100 million hit from tariffs this year.
Alcon shares fall after it cuts guidance and warns of tariff impact
Shares in Alcon fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on Tuesday flagging the impact of U.S. tariffs.
Alcon Non-GAAP EPS of $0.76 beats by $0.05, revenue of $2.58B misses by $60M
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical
GENEVA--(BUSINESS WIRE)--Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical.
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical
GENEVA--(BUSINESS WIRE)--Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical.
Alcon Q2 2025 Earnings Preview
Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS
AHMEDABAD, India--(BUSINESS WIRE)--Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the 37th Asia-Pacific Association of Cataract ...
An Overview of Alcon's Earnings
Alcon (NYSE: ALC) is gearing up to announce its quarterly earnings on Tuesday, 2025-08-19. Here's a quick overview of what investors should know before the release. Analysts are estimating that Alcon...